These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36624642)

  • 1. Chemistry Characterization and Application of Nanocrystals-based Drug Delivery System: Present to Future Perspective.
    Dhibar M; Chakraborty S; Kundu A; Laha P
    Pharm Nanotechnol; 2023 Jun; 11(3):265-275. PubMed ID: 36624642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocrystals Technology for Transdermal Delivery of Water-Insoluble Drugs.
    Liu Y; Zhao J; Wang L; Yan B; Gu Y; Chang P; Wang Y
    Curr Drug Deliv; 2018; 15(9):1221-1229. PubMed ID: 29779482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical Methods for Enhancing the Dissolution of Poorly Water-Soluble Drugs.
    Mahmood T; Sarfraz RM; Ismail A; Ali M; Khan AR
    Assay Drug Dev Technol; 2023; 21(2):65-79. PubMed ID: 36917562
    [No Abstract]   [Full Text] [Related]  

  • 4. Current strategies for oral delivery of BCS IV drug nanocrystals: challenges, solutions and future trends.
    Wang Y; Tan X; Fan X; Zhao L; Wang S; He H; Yin T; Zhang Y; Tang X; Jian L; Jin J; Gou J
    Expert Opin Drug Deliv; 2021 Sep; 18(9):1211-1228. PubMed ID: 33719798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of solid lipid nanoparticles-a review.
    Parhi R; Suresh P
    Curr Drug Discov Technol; 2012 Mar; 9(1):2-16. PubMed ID: 22235925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocrystals based mucosal delivery system: research advances.
    Liu Y; Shuai S; Huang G; Chen Y; Shen B; Yue P
    Drug Dev Ind Pharm; 2021 Nov; 47(11):1700-1712. PubMed ID: 35287534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vivo fate of nanocrystals.
    Lu Y; Qi J; Dong X; Zhao W; Wu W
    Drug Discov Today; 2017 Apr; 22(4):744-750. PubMed ID: 28088442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the study of drug nanocrystals.
    Shi J; Guo F; Zheng A; Zhang X; Sun J
    Pharmazie; 2015 Dec; 70(12):757-64. PubMed ID: 26817271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of injectable drug nanocrystals.
    Fuhrmann K; Gauthier MA; Leroux JC
    Mol Pharm; 2014 Jun; 11(6):1762-71. PubMed ID: 24766270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degrees of order: A comparison of nanocrystal and amorphous solids for poorly soluble drugs.
    Peltonen L; Strachan CJ
    Int J Pharm; 2020 Aug; 586():119492. PubMed ID: 32505579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of media milling and microfluidization methods for engineering of nanocrystals: a case study.
    Chogale M; Gite S; Patravale V
    Drug Dev Ind Pharm; 2020 Nov; 46(11):1763-1775. PubMed ID: 32912040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
    Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
    Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanonization strategies for poorly water-soluble drugs.
    Chen H; Khemtong C; Yang X; Chang X; Gao J
    Drug Discov Today; 2011 Apr; 16(7-8):354-60. PubMed ID: 20206289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanonization techniques to overcome poor water-solubility with drugs.
    Da Silva FLO; Marques MBF; Kato KC; Carneiro G
    Expert Opin Drug Discov; 2020 Jul; 15(7):853-864. PubMed ID: 32290727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance Parameters and Characterizations of Nanocrystals: A Brief Review.
    Chogale MM; Ghodake VN; Patravale VB
    Pharmaceutics; 2016 Aug; 8(3):. PubMed ID: 27589788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical Modifications and Nano Particulate Strategies for Improved Bioavailability of Poorly Water Soluble Drugs.
    Siddiqui K; Waris A; Akber H; Munir K; Mir M; Khan MW; Aman W; Fakhar-Ud-Din
    Pharm Nanotechnol; 2017; 5(4):276-284. PubMed ID: 29278217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution calorimetry as an alternative approach for dissolution testing of nanosuspensions.
    Kayaert P; Li B; Jimidar I; Rombaut P; Ahssini F; Van den Mooter G
    Eur J Pharm Biopharm; 2010 Nov; 76(3):507-13. PubMed ID: 20887787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products.
    Van Eerdenbrugh B; Van den Mooter G; Augustijns P
    Int J Pharm; 2008 Nov; 364(1):64-75. PubMed ID: 18721869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State of the Art of Pharmaceutical Solid Forms: from Crystal Property Issues to Nanocrystals Formulation.
    Couillaud BM; Espeau P; Mignet N; Corvis Y
    ChemMedChem; 2019 Jan; 14(1):8-23. PubMed ID: 30457705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising strategies for improving oral bioavailability of poor water-soluble drugs.
    Rocha B; de Morais LA; Viana MC; Carneiro G
    Expert Opin Drug Discov; 2023 Jun; 18(6):615-627. PubMed ID: 37157841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.